MedBlog

Cancer; Your Pregnancy Matters

Can uterine fibroids harm my pregnancy?

Large or multiple uterine fibroids can pose risks to mom and baby during pregnancy. Find out why in this week's Your Pregnancy Matters blog.

Jessica Shields, D.O.

March 31, 2020

Cancer; Digestive

Why you should consider clinical genetic testing for hereditary colon cancer

People are fascinated with the human genome at the moment, with the popularity of direct-to-consumer tests such as 23andMe soaring. But Interpreting genetic test results can be complicated, particularly for conditions like colon cancer. At UT Southwestern, our 14 genetic counselor works with patients before and after a comprehensive DNA analysis to determine if they have any hereditary risks.

Sayoni Lahiri

March 11, 2020

Cancer

Smarter radiation, fewer sessions: How SABR might help defeat metastatic cancer

Stereotactic ablative therapy (SABR) has proven effective in treating many types of primary tumors. Robert Timmerman, M.D., discusses how SABR might improve survival rates for patients with metastatic cancer.

Robert Timmerman, M.D.

February 13, 2020

Cancer

5 questions patients might be reluctant to ask about radiation therapy

Radiation therapy for cancer raises plenty of questions – some of which you might feel nervous asking. Nina Sanford, M.D, tackles five common questions patients might be afraid to bring up with their doctors. Read more.

Nina Sanford, M.D.

January 22, 2020

Cancer

Colorectal Cancer in Young Adults on the Rise

The rates of colorectal cancer in young adults have been on the rise, making screening more important than ever.

January 20, 2020

Cancer

Dedicated Clinic for Lymphoma Cancer Treatments

A dedicated clinic at UT Southwestern specializes in cutaneous lymphoma cancer treatment.

January 20, 2020

Cancer

Interventional Radiology Procedures to Fight Cancer

Using interventional radiology procedures to fight cancer allows doctors to guide treatments right to the cancer site.

January 20, 2020

Cancer

Identifying Cancer Biomarkers for Immunotherapy

Researchers have been identifying new cancer biomarkers for immunotherapy that can benefit patients. These three discoveries are some of the highlights.

January 19, 2020

Cancer; Transplant

Hepatitis C treatment can cut risk of liver-related death by 50% for patients with a history of liver cancer

This study looked at medical records for patients who were cured of liver cancer at 31 North American medical centers. The findings demonstrate that patients who were treated and cured of their hepatitis C had significantly better survival rates than those patients whose hepatitis C was not treated.

Amit Singal, M.D.

January 18, 2020

Cancer; Discovery; Prevention

Precision medicine, immunotherapy drive largest single-year drop in cancer deaths

Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.

John Sweetenham, M.D.

January 15, 2020